Review the use of High Sensitive Troponin I and NT-proBNP for health screening in asymptomatic populations. How would the results be explained?

The literature describes potential uses for hsTnI and NT-proBNP in cardiovascular health screening among asymptomatic populations, with evidence supporting their roles in improving risk prediction and identifying subclinical cardiac abnormalities. These findings are influenced significantly by demographic variables and comorbid conditions, requiring careful interpretation within clinical contexts.